AcquisitionMethod: HPLC-MS/MS
AcquisitionMethod: LC-MS/MS
AlkylationReagent: iodoacetamide (IAA)
Chromatography: C18
CleavageAgent: trypsin
Disease: colorectal cancer (CRC)
Experiment: proteomics
FlowRate: 4 microL/min
FlowRate: 200 nL/min
FragmentationMethod: Higher-energy collisional dissociation
FragmentationMethod: Collision-induced dissociation
GradientTime: 240 min
Instrument: Thermo Fisher Scientific
Instrument: Dionex Ultimate 3000 nanoHPLC System
Instrument: Thermo Scientific Q Exactive Mass Spectrometer
IonizationType: EasySpray source
IonizationType: nano-ESI
MS2Analyzer: Orbitrap
MissedCleavages: 2 miscleavages
MissedCleavages: 2
Modification: Carbamidomethylation
Modification: Methionine oxidation
Modification: Protein N-terminal acetylation
Organism: Homo sapiens
OrganismPart: rectal
OrganismPart: tumor tissues
ReductionReagent: Dithiothreitol
SearchEngine: MaxQuant
Separation: in-gel separation
Separation: HPLC-MS/MS
Separation: high performance liquid chromatography separation
Temperature: 98 degreesC
Temperature: 37 degreesC
Temperature: 40 degreesC
TumorGrade: TRG0 complete regression (non-viable cancer cells)
TumorGrade: TRG1 near complete regression (single or small groups of tumor cells)
TumorGrade: TRG2 moderate regression (residual cancer outgrown by fibrosis)
TumorGrade: TRG3 minimal/absent regression (minimal or no tumor cells killed)
TumorStage: T3-T4, any N, M0/any T, N1-N2, M0
TumorStage: iTNM
TumorStage: ypTNM
TumorStage: AJCC